Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes - Nissinen, T A; Degerman, J; Rasanen, M (Sci Rep, 2016)
et al.